Clinical Trials Browser

Phase 1/2 × Terminated × NET × Clear all

Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

NCT02592707 2023-07-19

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Phase 1/2 Terminated

40 enrolled 37 charts

EndocrineNET

Neuroendocrine Tumors

NCT02177773 2019-11-12

DOTA-TOC

Phase 1/2 Terminated

300 enrolled 5 charts

CNSEndocrineNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Neuroendocrine Tumors

NCT00323076 2019-08-26

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Phase 1/2 Terminated

92 enrolled

EndocrineGenitourinaryNET

Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT02078843 2016-09-07

GaIN

Phase 1/2 Terminated

54 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

Clinical Trials

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

DOTA-TOC

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

GaIN